The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma
ABSTRACT Background Malignant tumors release growth factors, promoting lymphangiogenesis in primary tumors and draining sentinel lymph nodes, ultimately facilitating lymph node metastasis. As a malignant lymphatic tumor entity, lymphangiosarcomas are characterized by low survival rates and limited t...
Saved in:
Main Authors: | Katja K. Koll, Martin M. Zimmermann, Patrick A. Will, Ulrich Kneser, Christoph Hirche |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generalized lymphatic anomaly in a pediatric patient manifesting as a rare presentation of hemorrhagic pleural effusion: a case report
by: Xuehong Zhang, et al.
Published: (2025-01-01) -
Lymphatic leaks – success of intranodal lymphangiogram first strategy
by: Alan Campbell, et al.
Published: (2025-01-01) -
Abdominal lymphatic malformations in children: case series
by: Carmine Noviello, et al.
Published: (2025-01-01) -
A Proposed Role for Lymphatic Supermicrosurgery in the Management of Alzheimer's Disease: A Primer for Reconstructive Microsurgeons
by: Joon Pio Hong, et al. -
The effects of variable spatial aggregation on lymphatic filariasis transmission
by: Callum Shaw, et al.
Published: (2025-01-01)